---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-040509"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2024-09-09T23:59:59+00:00"
generated_at: "2026-05-31T05:50:50.998897+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Galectin posts updated corporate presentation; no specific material changes detailed

## Summary
- Updated corporate presentation posted to website on September 9, 2024.
- Presentation intended for use at investor conferences and meetings.
- Filing does not disclose specific financial or pipeline updates beyond the presentation format.

## SEC filing metadata
- accession: 0001140361-24-040509
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2024-09-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036124040509/0001140361-24-040509-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036124040509/ef20034919_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-040509
- JSON: https://secwatch.observer/filing/0001140361-24-040509.json
- Plain text: https://secwatch.observer/filing/0001140361-24-040509.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.